Altrova Health Inc. ROVA
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 97.62% | 75.86% | 92.87% | -55.08% | -31.34% |
| Depreciation & Amortization | 1,460.00% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.01% | 93.52% | 92.87% | -50.66% | -30.12% |
| Operating Income | -105.48% | -68.20% | -92.87% | 52.23% | 33.00% |
| Income Before Tax | -188.09% | -56.63% | -54.52% | -248.55% | 37.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -188.09% | -56.63% | -54.52% | -248.55% | 37.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -188.09% | -56.63% | -54.52% | -248.55% | 37.84% |
| EBIT | -105.48% | -68.20% | -92.87% | 52.23% | 33.00% |
| EBITDA | -102.90% | -64.84% | -85.84% | 52.25% | 32.98% |
| EPS Basic | -150.00% | 3.45% | 31.58% | -97.06% | 79.22% |
| Normalized Basic EPS | -70.00% | 0.00% | 33.33% | 67.44% | 79.17% |
| EPS Diluted | -150.00% | 3.45% | 31.58% | -97.06% | 79.22% |
| Normalized Diluted EPS | -70.00% | 0.00% | 33.33% | 67.44% | 79.17% |
| Average Basic Shares Outstanding | 14.46% | 62.02% | 118.57% | 77.42% | 206.33% |
| Average Diluted Shares Outstanding | 14.46% | 62.02% | 118.57% | 77.42% | 206.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |